Niosome: A Novel Drug Delivery System by Mujoriya, Rajesh et al.
Innovative Systems Design and Engineering       www.iiste.org 
ISSN 2222-1727 (Paper) ISSN 2222-2871 (Online) 
Vol 2, No 3 
Niosome – A Novel Drug Delivery System 
 
Rajesh Mujoriya (Corrosponding Authors) 
Sardar patel college of technology, {b-pharmacy} 
Balaghat, dis. Balaghat, {m.p.} – 481001,INDIA 
Tel. No. +918817517515,  E-mail: raj_mujoriya@indiatimes.com, raj_mujoriya@live.com 
 
Diwakar Singh 
Sardar patel college of technology, {b-pharmacy} 
Balaghat, dis. Balaghat, {m.p.} – 481001,INDIA 
Tel. No. +919425138573, E-mail:- spctgroups@gmail.com 
 
Ramesh Babu Bodla
 
K.I.E.T. School of pharmacy, Gaziabad, India 
E-mail:- ramesh_bodla@rediffmail.com 
. 
Kishor Dhamande 
Sardar patel college of technology, {b-pharmacy} 
Balaghat, dis. Balaghat, {m.p.} – 481001,INDIA 
Tel. No. +919977572170, E-mail: kdmrox@gmail.com 
Abstract  
 
The concept of drug targeting or site specific drug delivery was introduced first time by Paul Elrich in 1909, when 
he reported ‘magic bullet’ to deliver a drug to the desired site of action without affecting the non target organs or 
tissues (Juliano, 1980) by associating the drug with a pharmacologically “inactive carrier” capable of conveying the 
drug selectively towards its target cells. The main goal of a site specific drug delivery system is not only to increase 
the selectivity and drug therapeutic index, but also to reduce the toxicity of the drug. 
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Introduction 
 
Target oriented drug delivery systems are the areas of the major interest in the modern pharmaceutical research. The 
selective drug delivery to the target tissues increases the therapeutic efficacy of the drug and reduces its undesirable 
effect to non target tissues. The main goal of a site specific drug delivery system is not only to increase the 
selectivity and drug therapeutic index, but also to reduce the toxicity of the drug. (Widder et al., 1982). Rheumatoid 
arthritis (RA) is a chronic, inflammatory condition of unknown eitiology that affects about 1% of general population 
(Feldmann et. al., 1996) and is the most common cause of chronic inflammatory synovitis (Watson-Clark et al., 
1998). Although spontaneous remission can occur, it often progresses to chronic state associated with significant 
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functional disability (Geletka and Clair, 2003). A number of drugs are used in the treatment of RA over the past 10-
20 years. An ideal therapy in RA should ameliorate disease, prevent the development of extra-articular 
complications such as vasculitis, serositis and lung fibrosis and prevent premature death (Rabinovich, 2000). 
 
1.1) Merits Of Novel Drug Delivery System :  
 
1) Improved patient compliance resulting from the reduction in the frequency of doses required  to maintain the desired 
therapeutic response. 
2) Targeting of the drug molecule towards the tissue (or) organ reduces the toxicity to the normal tissues. 
3) Pulsatile and pH dependent systems release the drug whenever the body demands. 
4) Biocompatibility. 
5) Economic and better savings are claimed from better disease management achieved with this system. 
 
1.2) Limitations of novel drug delivery system :  
 
Through there are number of advantages in NDDS system, there are a few factors that limit its usage. 
1. Variable physiological factors such as gastrointestinal pH, enzyme activities, gastric and intestinal transit  
rates. The food and severity of patient’s disease often influences drug bioavailability from conventional dosage 
forms and may interfere with the precision of control release and absorption of drug from such system. 
2. The products which tend to remain intact may get lodged at some sites. If this occurs, slow release of the  
 drug from the dosage form may produce a high localized concentration of drug causing local irritation.  
3. The drugs having biological half-life of 1 hr. or less are difficult to be formulated as sustained release  
formulations. The high rate of elimination of such drugs from the body needs an extremely large maintenance dose 
which provides 8-12 hrs of continuous therapy. 
4. These products normally contain a large amount of drug. There is a possibility of unsafe over dosage, if the product 
is improperly made and the total drug contained therein is released at one time or over too short time interval. 
 
 
Types Of Niosomes 
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The niosomes are classified as a function of the number of bilayer (e.g. MLV, SUV) or as a function of size. (e.g. 
LUV, SUV) or as a function of the method of preparation (e.g. REV, DRV). The various types of niosomes (Weiner 
et al., 1989) are described below. 
i) Multi lamellar vesicles (MLV) 
ii) Large unilamellar vesicles (LUV) 
iii) Small unilamellar vesicles (SUV) 
 
(i) Multilamellar vesicles (MLV): It consists of a number of bilayer surrounding the aqueous lipid compartment 
separately. The approximate size of these vesicles is 0.5-10 µm diameter. Multilamellar vesicles are the most widely 
used niosomes (Bangham et al., in 1974). It is simple to make and are mechanically stable upon storage for long 
periods. These vesicles are highly suited as drug carrier for lipophilic compounds. 
(ii) Large unilamellar vesicles (LUV): Niosomes of this type have a high aqueous/lipid compartment ratio, so that larger 
volumes of bio-active materials can be entrapped with a very economical use of membrane lipids. 
(iii) Small unilamellar vesicles: These small unilamellar vesicles are mostly prepared from multilamellar  
vesicles by sonication method, French press extrusion method or, homogenization method. The approximate sizes of 
small unilamellar vesicles are 0.025-0.05 µcm diameter. They are thermodynamically unstable and are susceptible to 
aggregation and fusion. Their entrapped volume is small and percentage entrapment of aqueous solute is 
correspondingly low. 
 
 
 
Methods Of Preparation For Niosomes 
The methodology for niosome preparation has been evolved rapidly during the last few years as a response to 
prepare well defined niosomes for specific applications. 
 
3.1.1) Multi Lamellar Vesicles (Mlv) 
 
Bangosomes popularly known as multilamellar vesicles are prepared as per the method described by Bangham et al., 
1974. In this method the lipids are dissolved in an organic solvent in a round bottom flask. A thin lipid layer is 
formed on the inside wall of the flask after removal of the organic solvent by rotatory evaporation at reduced 
pressure. 
Multilamellar vesicles are formed spontaneously when an excess volume of aqueous buffer is added to the dry lipid. 
After shaking (by hand or vortex mixer), it results in formation of dispersion of multilamellar vesicles. Duration and 
intensity of shaking, the presence of charge inducing agents in the bilayer, ionic strength of the aqueous medium and 
lipid concentration are the important parameters influencing the size and the encapsulating efficiency of 
multilamellar vesicles. The lipids formed are quite heterogeneous both in size and in the number of lamella. 
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3.1.2) Small Unilamellar Vesicles (Suv) 
 
(A) Sonication: In this method, the preparation of small lamellar vesicles has been reviewed by Bangham 
(Bangham et al., 1974). The usual multilamellar vesicles and large unilamellar vesicles are sonicated either with a 
bath type sonicator or a probe sonicator, under an inert atmosphere (usually nitrogen or argon) to get the small 
unilamellar vesicles. During sonication, the multilamellar vesicles are broken down and small unilamellar vesicles 
with high radius of curvatures are formed. 
(B) French press method: Dispersions of MLV’s can be converted to small unilamellar vesicles by passage 
through a small orifice under high pressure (Berenholz et al., 1977). A French pressure cell was used by Hamilton 
and Guo in 1984. Multilamellar vesicles dispersion is placed in the French press and extruded at about 20000 psi at 
4
o
C(Hamilton and Guo, 1984): On passing through the cell, a heterogeneous population of vesicles are formed 
ranging from several micrometers in diameter to small unilamellar vesicles size. Multiple extrusions results in a 
progressive decrease in the mean particle diameter (30-80nm) depending upon the pressure used. These niosomes 
are more stable than sonicated ones and can be used advantageously as drug delivery carriers. 
(C) Ethanol injection method: An alternative method for producing small niosomes that avoids both sonication 
and high pressure is the ethanol injection method, first described by Batzri and Korn in 1973. In this method, the 
lipid is dissolved in ethanol and is rapidly injected into an excess of buffer solution or other aqueous medium though 
a needle. The force of the injection is usually sufficient to achieve complete mixing, so that the ethanol is diluted 
almost instantaneously in water and the phospholipids molecules are dispersed evenly throughout the medium. 
 
3.1.3) Large unilamellar vesicles (LUV) 
 
Large unilamellar vesicles provide a number of important advantages as compared to the multilamellar vesicles 
including high encapsulation of water soluble drugs with economy of lipid and reproducible drug release rates. 
However, large unilamellar vesicles are perhaps the most difficult type of niosomes to produce. 
(A) Reverse phase evaporation method: Large Unilamellar vesicles can be prepared by forming water in oil 
emulsion of phospholipids and buffer in the excess organic phase followed by removal of the organic phase under 
reduced pressure. The two phases are usually emulsified by sonication. Removal of the organic solvent under 
vacuum causes phospholipid coated water droplets to cool and eventually form a viscous gel. The next step is to 
bring about the collapse of certain proportion of water droplets. 
(B) Calcium induced method: This method is used to produce unilamellar vesicles and it is of high interest for 
the present investigation as it has the advantage of aggregation of small vesicles in the presence of calcium followed 
by subsequently fusion. 
In this method (Papahadjopoulos et al., 1975) the drug encapsulation depends on the lipid concentration and 
approximately 30% of encapsulation of the drug is expected. The vesicles are obtained in the size range of 0.2-1 
µcm diameter. 
 (C) Dehydration/rehydration of small unilamellar vesicles: In this method (Shew and Deamer,1985) sonicated 
vesicles are mixed in an aqueous solutions with the solute desired to be encapsulated and the mixture is dried under 
a stream of nitrogen. As the sample is dehydrated, the small vesicles fuse to form a multilamellar film that 
effectively sandwich’s the solute molecules between successive layers. Upon rehydration, large vesicles are 
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produced encapsulating a significant proportion of the solute. The optimal mass ratio of lipid to solute is 
approximately 1:2 to 1:3. This method has the potential application to large scale production, since it depends only 
on controlled drying and rehydration processes and does not require extensive use of organic solvents, detergents or 
dialysis system. 
 
3.2) Equipments Required For Preparation :  
        Given in the table mention below (Table 1) 
 
 
Conclusion :  
 
Niosomes are efficient carriers for controlled drug delivery, to entrap hydrophilic drugs in the larger interior aqueous 
layer , whereas, lipophilic drugs in the outer lipid bilayer. Since, the niosomes, are biodegradable and non toxic and 
hence, a good carrier for targeting of therapeutic agents at the site of interest  with reduced systemic toxicity. 
The success of liposomal system has stimulated the search for other vesicle forming amphiphiles. Non-ionic 
surfactant vesicles (niosomes) are among the first alternative materials studied for the drug delivery. 
Niosomes, the multilamellar vesicles made up of non-ionic surfactant with or without cholesterol surrounding 
aqueous compartments are one of those carriers. 
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Table 1 : Equipments Required For Preparation 
 
Sr. 
No. 
 
Equipment 
1. UV-Visible Spectrophotometer 
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2. Digital pH meter 
3. Electronic Balance 
4. Rotary vacuum evaporator 
5. Microscope 
6. Vacuum Pump 
7. Magnetic Stirrer with hot plate 
8. Research Centrifuge 
9. Digital Vernier Caliper 
10. Transmission electron microscope 
11. Water Bath 
12. Diffusion Cell 
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